Loading chat...

HI HB1602

Bill

Official Source

Status

Passed

7/11/2018

Primary Sponsor

Cynthia Thielen

Click for details

Origin

House of Representatives

2018 Regular Session

AI Summary

  • Requires health care professionals and pharmacists to include a warning label on opioid drug packages stating "Caution: Opioid. Risk of overdose and addiction."

  • Warning label requirement applies to all opioid drugs dispensed in addition to existing federal and state labeling requirements under Hawaii Revised Statutes Chapter 328 and Chapter 329.

  • Warning label requirement becomes effective August 1, 2018, while the Act takes effect upon approval.

  • Establishes new statutory provision in Hawaii Revised Statutes Chapter 329, Part III to mandate the opioid warning label on drug packaging.

Legislative Description

Relating To Opioids.

Warning Label

Last Action

Act 151, 07/09/2018 (Gov. Msg. No. 1260).

7/11/2018

Committee Referrals

Commerce, Consumer Protection, and Health3/8/2018
Consumer Protection & Commerce2/16/2018
Health & Human Services1/17/2018

Full Bill Text

No bill text available